Who invested in Ambrosia Biosciences?
Ambrosia Biosciences's investors include Janus Henderson Investors, Redmile Group, Samsara BioCapital and Blue Owl.
United States · Series B startup
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 8 months ago
Funding summaryUpdated 26 Oct 2026
$100Mraised across 1 round since 2026, from 1 source
Ambrosia Biosciences's investors include Janus Henderson Investors, Redmile Group, Samsara BioCapital and Blue Owl.
Ambrosia Biosciences has raised $100M across 1 round since 2026.
Ambrosia Biosciences's most recent round was a Series B of $100M in Mar 2026.
Its most recent round, $100M in Mar 2026, is also its largest on record.
Ambrosia Biosciences's first round on record, in Mar 2026, was backed by Janus Henderson Investors, Redmile Group and Samsara BioCapital and 1 others.
Ambrosia Biosciences's latest named round is a Series B, in Mar 2026.
Ambrosia Biosciences is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.